Medicine guide

LYTGOBI

As listed in the register: LYTGOBI 4 mg, comprimé pelliculé

4 mg · comprimé pelliculé

  • Prescription only
Active substance
Futibatinib
Made by
TAIHO PHARMA NETHERLANDS (PAYS-BAS)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byTAIHO PHARMA NETHERLANDS (PAYS-BAS)
Active substanceFutibatinib
Strength4 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/23/1741
Name in the registerLYTGOBI 4 mg, comprimé pelliculé
Packsplaquette(s) PVC polychlortrifluoroéthylène aluminium de 35 comprimé(s)
CIS68552628
CIP133400930276600

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).